Revision history of "Randomised, double-blind, placebo-controlled clinical trial of melatonin as adjuvant therapy to primary angioplasty in acute myocardial infarction — MARIA study." (Q3144278)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

20 March 2024

20 December 2023

12 June 2023

10 June 2023

17 August 2022

  • curprev 20:5620:56, 17 August 2022DG Regio talk contribs 67,672 bytes +45,965 Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

17 December 2021

9 December 2021

2 December 2021

  • curprev 15:2915:29, 2 December 2021DG Regio talk contribs 14,654 bytes +2,238 Created claim: summary (P836): Objectif principal: Évaluer l’efficacité de la mélatonine intraveineuse et intracoronarienne dans l’infarctus aigu du myocarde traité par angioplastie primaire, afin de réduire la taille de la zone de nécrose grâce à une protection contre les dommages oxydatifs par reperfusion. Objectifs secondaires: Événements cardiovasculaires majeurs composés à 30 et 365 jours par: infarctus aigu du myocarde, angor instable, angioplastie coronaire translumin...
  • curprev 15:2915:29, 2 December 2021DG Regio talk contribs 12,416 bytes +266 Changed label, description and/or aliases in fr: translated_label

12 October 2021

  • curprev 14:0114:01, 12 October 2021DG Regio talk contribs 12,150 bytes +223 Changed label, description and/or aliases in en: translated_label
  • curprev 14:0114:01, 12 October 2021DG Regio talk contribs 11,927 bytes +2,016 Created claim: summary (P836): Main objective: Evaluate the efficacy of intravenous and intracoronary melatonin in acute myocardial infarction treated with primary angioplasty, to reduce the size of the necrosis area through protection against oxidative damage by reperfusion. Secondary objectives: Major cardiovascular events composed at 30 and 365 days by: acute myocardial infarction, unstable angina, coronary transluminal angioplasty, myocardial revascularisation surgery, s...

10 October 2021

9 October 2021

8 October 2021